StatPearls, LLC

  • Asthma
  • Bronchial Hyperreactivity
  • Nebulizers and Vaporizers
  • Patient Acceptance of Health Care

Asthma Medications

Asthma is a common chronic respiratory disease that continues to challenge clinicians despite the availability of effective therapies. Characterized by airway inflammation, bronchial hyperreactivity, and mucus overproduction, asthma frequently leads to poor symptom control, recurrent exacerbations, and increased health care utilization. Optimal management requires a thorough understanding of evolving pharmacologic options and adherence to evidence-based guidelines. This activity provides a focused review of asthma medications, including their mechanisms of action, clinical indications, and safety profiles. Learners will explore how these therapies align with current guideline-based recommendations and strategies for individualized treatment selection. The course emphasizes practical approaches to improving medication efficacy, minimizing adverse effects, and addressing common barriers such as improper inhaler technique. Interprofessional collaboration among physicians, nurses, pharmacists, and respiratory therapists is highlighted as essential to optimizing patient outcomes. Participation in this activity enhances clinical competence in delivering patient-centered, evidence-based asthma care.

Credit & MOC Details

Credit information is provided by the course provider. We recommend confirming credit eligibility with the provider or your licensing board before starting the activity.

Credit types

AAPA Category 1 Credit™Up to 2 creditsAMA PRA Category 1 Credit™Up to 2 creditsNursingUp to 2 creditsPharmacyUp to 2 credits

MOC types

ABS — Accredited CMEUp to 2 pointsABOS — Accredited CMEUp to 2 pointsABPATH — Lifelong LearningUp to 2 pointsABA — Lifelong LearningUp to 2 pointsABTS — Accredited CMEUp to 2 pointsABIM — Medical KnowledgeUp to 2 pointsABS — Self-AssessmentUp to 2 pointsABP — Lifelong Learning and Self-AssessmentUp to 2 pointsABTS — Self-AssessmentUp to 2 points

FDA REMS

No

Qualifies for MIPS

No

Target Specialties

Cross-Specialty

Relevant across 11 specialties.

Pricing

Fee varies

This provider typically $49–98

See fees on statpearls.com

Listed by the provider

  • Article / monograph / reference
  • Credit · Up to 2 credits
  • MOC · Up to 2 points
  • Fee varies · this provider typically $49–98
  • Released
    Sep 1, 2026
  • Last day to claim credit
    Sep 1, 2029 3 years left